Group structure
3 companies in 2 countries
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine of every company in the group, current ones first.
1–25 of 53
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ATROPINE1 % · Solution | Atropine | Canada | Marketed | 1994 |
| BALANCED SALT SOLUTION0.48 mg / ml + 0.3 mg / ml + 0.75 mg / ml + 3.9 mg / ml + 6.4 mg / ml + 1.7 mg / ml · Solution | Calcium chloride, Magnesium chloride, Potassium chloride, Sodium acetate, Sodium chloride, Sodium citrate | Canada | Not marketed | 1994 |
| Bimatoprost Stulln 0,3 mg/ml oogdruppels, oplossing in verpakking voor eenmalig gebruikOogdruppels, oplossing | Bimatoprost | Netherlands | Authorised | 2026 |
| Bimatoprost Stulln zonder conserveermiddel 0,3 mg/ml oogdruppels, oplossingOogdruppels, oplossing | Bimatoprost | Netherlands | Authorised | 2019 |
| BRIMONIDINA STULLNCollirio, soluzione | Brimonidine | Italy | Authorised | |
| Brimonidine Stulln 2 mg/ml oogdruppels, oplossing in verpakking voor éénmalig gebruikOogdruppels, oplossing | Brimonidine | Netherlands | Authorised | 2019 |
| BRIPIO 2 MG/ML COLIRIO EN SOLUCION EN ENVASE UNIDOSIS2 mg/ml · Colirio en solución en envase unidosis | Brimonidine | Spain | Marketed | 2019 |
| CHLORAMPHENICOL0.5 % · Solution | Chloramphenicol | Canada | Not marketed | 1994 |
| DEXAMETHASONE0.1 % · Solution | Dexamethasone | Canada | Marketed | 1994 |
| DICLOFENAC0.1 % / w/v · Solution | Diclofenac | Canada | Marketed | 2019 |
| DIOPTICON A LIQ0.025 % + 0.3 % · Solution | Naphazoline, Pheniramine | Canada | Not marketed | 1994 |
| DIOPTICON LIQ 0.1%0.1 % · Solution | Naphazoline | Canada | Not marketed | 1994 |
| DIOPTROL SUSPENSION1 mg / ml + 3.5 mg / ml + 10000 unit / ml · Suspension | Dexamethasone, Neomycin, Polymyxin b | Canada | Not marketed | 1994 |
| DIOROUGE LIQ0.5 % + 0.125 % + 1.4 % · Solution | Pheniramine, Phenylephrine, Polyvinyl alcohol | Canada | Not marketed | 1994 |
| DORZOLAMIDA/TIMOLOL STULLN 20 MG/ML + 5 MG/ML COLIRIO EN SOLUCION22,26 mg + 6,83 mg · Colirio en solución | Dorzolamide, Timolol | Spain | Authorised | 2020 |
| DORZOLAMIDA/TIMOLOL STULLN PF 20 MG/ML + 5 MG/ML COLIRIO EN SOLUCION EN ENVASE UNIDOSIS22,26 mg + 6,83 mg · Colirio en solución en envase unidosis | Dorzolamide, Timolol | Spain | Authorised | 2020 |
| Dorzolamide + Timolol Stulln 20 mg/ml + 5 mg/ml oogdruppels, oplossingOogdruppels, oplossing | Dorzolamide, Timolol | Netherlands | Authorised | 2019 |
| Dorzolamide + Timolol Stulln zonder conserveermiddel 20 mg/ml + 5 mg/ml oogdruppels, oplossing in verpakking voor éénmalig gebruikOogdruppels, oplossing | Dorzolamide, Timolol | Netherlands | Authorised | 2019 |
| ERYTHROMYCIN5 mg / g · Ointment | Erythromycin | Canada | Marketed | 1997 |
| FLUORESCEIN100 mg / ml · Solution | Fluorescein | Canada | Not marketed | 1994 |
| Hylan 0,15/0,15 mg/ml, oogdruppels, oplossing in verpakking voor eenmalig gebruikOogdruppels, oplossing | Carbomer, Natriumhyaluronaat | Netherlands | Authorised | 2015 |
| Hylan Forte 1,5/0,15 mg/ml, oogdruppels, oplossing in verpakking voor eenmalig gebruikOogdruppels, oplossing | Carbomer, Natriumhyaluronaat | Netherlands | Authorised | 2025 |
| Ipratropiumbromide/Salbutamol Stulln Unit Dose 0,5/2,5 mg per 2,5 ml, verneveloplossingVerneveloplossing | Ipratropium bromide, Salbutamol | Netherlands | Authorised | 2013 |
| KETOBRILL 0,25 mg/ml COLIRIO EN SOLUCIÓN EN ENVASE UNIDOSIS0,345 MG/ML mg · Colirio en solución en envase unidosis | Ketotifen | Spain | Marketed | 2013 |
| Ketotifen Stulln 0,25 mg/ml oogdruppels, oplossing in verpakking voor éénmalig gebruikOogdruppels, oplossing | Ketotifen | Netherlands | Authorised | 2019 |